Canopy Growth Corp Deferred Tax Assets, Operating Loss Carryforwards
Canopy Growth Corp (CGC) had Deferred Tax Assets, Operating Loss Carryforwards of CAD 1.18 billion as of 2026-03-31, per its 10-K filed 2026-06-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-06-15
- 2026-03-31: Deferred Tax Assets, Operating Loss Carryforwards 1.18B CAD.
- 2025-03-31: Deferred Tax Assets, Operating Loss Carryforwards 1.18B CAD.
- 2024-03-31: Deferred Tax Assets, Operating Loss Carryforwards 1.12B CAD.
- 2023-03-31: Deferred Tax Assets, Operating Loss Carryforwards 1.06B CAD; Deferred Tax Assets, Operating Loss Carryforwards as first filed 1.14B CAD.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2026-03-31 | 1.18B CAD 10-K · filed 2026-06-15 | |
| 2025-03-31 | 1.18B CAD 10-K · filed 2026-06-15 | |
| 2024-03-31 | 1.12B CAD 10-K · filed 2025-05-30 | |
| 2023-03-31 | 1.06B CAD 10-K · filed 2024-05-30 | 1.14B CAD 10-K · filed 2023-06-22 |
| 2022-03-31 | 919.96M CAD 10-K · filed 2023-06-22 | 917.28M CAD 10-K · filed 2022-05-31 |
| 2021-03-31 | 608.00M CAD 10-K · filed 2022-05-31 | |
| 2020-03-31 | 300.33M CAD 10-K · filed 2021-06-01 | |
| 2019-03-31 | 108.99M CAD 10-K · filed 2020-06-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |